Extendicare Announces July 2026 Dividend of C$0.0441 per Share
Markham, Ontario--(Newsfile Corp. - July 15, 2026) - Extendicare Inc. (TSX: EXE) ("Extendicare" or the "Company") announced that it has declared a cash dividend of C$0.0441 per common share of the Company for the month of July 2026, which is payable on August 17, 2026 to shareholders of record at the close of business on July 31, 2026. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada). About Extendicare Extendicare
Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-07-15 8:00 AM EDT | Extendicare Inc.
Phio Pharmaceuticals Announces Patent Milestone with Multiple Notices of Allowance and Grant Decision
King of Prussia, Pennsylvania--(Newsfile Corp. - July 15, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio Pharmaceuticals announced today significant progress in the protection of its proprietary innovations across key international markets. The company has received multiple favorable patent actions encompassing three
Biotechnologies, Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-07-15 7:00 AM EDT | Phio Pharmaceuticals Corp.
Trenchant Technologies Capital Corp. Announces Closing of First Tranche of the Private Placement of Convertible Debentures
Toronto, Ontario--(Newsfile Corp. - July 14, 2026) - Trenchant Technologies Capital Corp. (CSE: AITT) (OTC Pink: AITTF) ("Trenchant" or the "Company") is pleased to announce that, further to its news release of July 03, 2026, that it has closed a first tranche on July 10, 2026 (the "First Tranche") of its private placement (the "Offering"), and has issued 500 debentures (the "Debentures") for gross proceeds of $500,000. Trenchant anticipates closing the rema
Technologies, Services bancaires / financiers, Biotechnologies, Soins de santé et hôpitaux
2026-07-14 8:13 PM EDT | Trenchant Technologies Capital Corp.
LevelJump Announces 2026 Q1 Financial Results
Toronto, Ontario--(Newsfile Corp. - July 14, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), is pleased to announce its financial results for the quarter ended March 31, 2026. Financial and Operational Highlights Revenues were $4.7 million in the first quarter of 2026 compared to $4.58 million in revenues for the first quarter of 2025, a year over year revenue increase of 2.7%. Canadian Teleradiology Se
Soins de santé et hôpitaux, Santé
2026-07-14 7:00 PM EDT | LevelJump Healthcare Corp.
LevelJump Announces 2025 Financial Results
Toronto, Ontario--(Newsfile Corp. - July 14, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), is pleased to announce its financial results for the year ended December 31, 2025. Financial and Operational Highlights Revenues were $19.1 million in 2025 compared to $17.7 million in revenues for 2024, a year over year revenue increase of 7.9%. Canadian T
Soins de santé et hôpitaux, Santé
2026-07-14 6:30 PM EDT | LevelJump Healthcare Corp.
Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant
White Bear Lake, Minnesota--(Newsfile Corp. - July 14, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced positive 12-month data from the first 10 participants in Stage 1 of its pivotal clinical trial evaluating the investigational fully implanted Acclaim® cochlear implant. The Stage 1 cohort demonstrated a mean Consonant-Nucleus-Consonant ("CNC") word recognition
Biotechnologies, Soins de santé et hôpitaux
2026-07-14 9:17 AM EDT | Envoy Medical, Inc.
TelyRx Expands Operations in Clearwater, Fla., Tripling Footprint to Meet Growing Demand for Digital Healthcare
Clearwater, Florida--(Newsfile Corp. - July 14, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a digital healthcare and online pharmacy platform, today announced a major expansion of its Clearwater headquarters and pharmacy operations, following the milestone of one million prescriptions filled and first-quarter revenue growth of 180% year-over-year. The move more than triples TelyRx's overall footprint to meet growing consumer
Soins de santé et hôpitaux, Santé
2026-07-14 7:00 AM EDT | TelyRx
Discovery Senior Living Structures and Participates in Strategic Off-Market Transaction Between Capital Providers, Retains 36-Community Portfolio
Bonita Springs, Florida--(Newsfile Corp. - July 13, 2026) - Discovery Senior Living ("Discovery" or the "Company"), and its affiliated companies, one of the largest and most trusted seniors housing operators in the U.S., today announced it has retained management of a 36-community assisted living portfolio following multi-party transactions between two long-standing capital providers on the Discovery platform, Discovery and certain principals of the Company. Discovery played a central
Soins de santé et hôpitaux, Immobilier, Logement
2026-07-13 5:18 PM EDT | Discovery Senior Living
Adia Med's Rise, Highlighting 2.5 Years of Growth Toward NASDAQ
Winter Park, Florida--(Newsfile Corp. - July 13, 2026) - Adia Med Inc. (OTCQB: ADIA) (formerly Adia Nutrition Inc.), focused on regenerative medicine, stem cell therapies, and biologics, today highlighted its rapid advancement and major milestones achieved since the January 2024 leadership transition.
Soins de santé et hôpitaux, Santé
2026-07-13 9:00 AM EDT | Adia Med Inc.
WELL Health Announces Pricing of $150 Million Senior Unsecured Notes Offering
WELL has priced its inaugural offering of $150 million of senior unsecured notes due 2031, bearing interest at 6.875% per annum. Net proceeds will be used to fully repay WELL's convertible debentures due December 2026 and for general corporate purposes. The Offering extends WELL's debt maturity profile to 2031 and strengthens the Company's balance sheet to support continued growth in Canada. All amounts in
Technologies, Logiciels, Soins de santé et hôpitaux, Santé
2026-07-13 6:30 AM EDT | WELL Health Technologies Corp.
TelyRx Holdings Inc. Announces DTC Eligibility for U.S. Traded Shares
Clearwater, Florida--(Newsfile Corp. - July 10, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a digital healthcare and online pharmacy platform, today announced that its subordinate voting shares are now eligible for electronic clearing and settlement in the United States through the Depository Trust Company ("DTC"). DTC eligibility is expected to simplify trading, improvement settlement efficiency, and enhance the liquidity a
Soins de santé et hôpitaux, Santé
2026-07-10 7:00 AM EDT | TelyRx
Adia Nutrition to Trade as Adia Med Inc. After Lightning-Fast FINRA Review
Winter Park, Florida--(Newsfile Corp. - July 9, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA) announced today that FINRA has processed its corporate name change to Adia Med Inc. on an expedited timeline. The name change will be reflected on the FINRA Daily List today, with trading under the new name expected to begin tomorrow, Friday, July 10, 2026, on the OTC Markets.
Soins de santé et hôpitaux, Santé
2026-07-09 8:00 AM EDT | Adia Med Inc.
medmix Strengthens Its Innovation Portfolio with the Launch of FleXa(TM)
Baar, Switzerland--(Newsfile Corp. - July 9, 2026) - medmix introduces FleXa™, a new customizable syringe platform that advances precision and branding for single-component dental materials. This mod
Technologies, Construction / bâtiments, Soins de santé et hôpitaux, Produits ménagers / de consommation / cosmétiques
2026-07-09 3:41 AM EDT | medmix AG
TelyRx to Present at the Global Technology Virtual Investor Conference July 9, 2026
Clearwater, Florida--(Newsfile Corp. - July 8, 2026) - Hot on the heels of its one million prescriptions filled milestone, TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a technology-enabled healthcare and online pharmacy platform focused on expanding access to FDA-approved medications across the United States, announced today that Vanessa Slowey, President and Chief Executive Officer, and John Cascio, Chief Financial Officer, will present live at t
Soins de santé et hôpitaux, Santé
2026-07-08 1:05 PM EDT | TelyRx
Adia Nutrition Inc. Enters FINRA Home Stretch for Corporate Name Change to Adia Med Inc.
Winter Park, Florida--(Newsfile Corp. - July 7, 2026) - Adia Nutrition Inc. (OTCQB: ADIA) today announced it has entered the final stage of its corporate name change application from Adia Nutrition Inc. to Adia Med Inc. After several months of review by the Financial Industry Regulatory Authority (FINRA), including three rounds of comments and the submission of detailed supporting documentation, the Company believes it has now met all outstanding requirements. FINRA approval is anticipated wi
Soins de santé et hôpitaux, Santé
2026-07-07 10:19 AM EDT | Adia Med Inc.
ALST Health Brands Signs Memorandum of Understanding to Produce "Beyond the Game Network" Reality Soccer Series
Toronto, Ontario--(Newsfile Corp. - July 7, 2026) - ALST Health Brands (OTCID: ALST) today announced the execution of a Memorandum of Understanding (MOU) to develop and produce a new reality soccer series, "Beyond the Game Network." The agreement formalizes a strategic partnership to create original unscripted content that highlights player journeys, community impact, and the intersection of sport, health, and culture. Key elements of the MOU:
Soins de santé et hôpitaux, Commerce de détail, Santé
2026-07-07 8:16 AM EDT | AllStar Health Brands, Inc.
Extendicare Announces Timing of 2026 Second Quarter Results and Conference Call
Markham, Ontario--(Newsfile Corp. - July 7, 2026) - Extendicare Inc. (TSX: EXE) ("Extendicare" or the "Company") announced today that it plans to release its financial results for the second quarter of 2026 after market close on Thursday, August 6, 2026. A conference call hosted by Michael Guerriere, President and Chief Executive Officer and David Bacon, Executive Vice President and Chief Financial Officer, will be held on Friday, August 7, 2026, at 11:30 a.m. (EDT) to discuss the result
Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-07-07 8:00 AM EDT | Extendicare Inc.
FendX Engages Technical Development and Design Expertise to Advance Its Surface Contamination Detection App Program
Vancouver, British Columbia--(Newsfile Corp. - July 7, 2026) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), a technology company developing surface-protection solutions to reduce the spread of harmful pathogens, is pleased to announce that it has entered into two Statements of Work ("SOWs") dated July 6, 2026, to support the engineering and interface design of FendX's AI-driven surface contamination detection app using
Technologies, Soins de santé et hôpitaux, Santé
2026-07-07 7:00 AM EDT | FendX Technologies Inc.
ALZAI Health Corp. Announces Validation of Its AI-Driven Alzheimers Disease Risk Screening Solution on Large-Scale U.S. Patient Data
Toronto, Ontario--(Newsfile Corp. - July 6, 2026) - ALZAI Health Corp. (TSXV: ALZI) ("ALZAI" or the "Company"), is pleased to announce the validation of its proprietary artificial intelligence-driven Alzheimer's disease risk identification models using a large-scale U.S. longitudinal healthcare dataset, representing a significant milestone in the Company's potential U.S. commercialization. The validation demonstrated that ALZAI's risk-stratification models achieved performance on-par wi
Technologies, Logiciels, Soins de santé et hôpitaux
2026-07-06 6:00 AM EDT | Alzai Health Corp.
Trenchant Technologies Capital Corp. Announces Private Placement Offering of up to $1 Million Convertible Debentures
Vancouver, British Columbia--(Newsfile Corp. - July 3, 2026) - Trenchant Technologies Capital Corp. (CSE: AITT) (the "Company" or "Trenchant") is pleased to announce a private placement (the "Offering") of convertible debentures (each, a "Debenture") for gross proceeds of up to $1,000,000. The Offering consists of the issuance of convertible debentures of the Company (the "Debentures") bearing interest at a rate of 12% per annum and maturing one year f
Technologies, Services bancaires / financiers, Biotechnologies, Soins de santé et hôpitaux
2026-07-03 4:00 PM EDT | Trenchant Technologies Capital Corp.